Variant report

Variant	nsv1034289
Chromosome Location	chr5:116364840-116408396
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:66)
CpG islands
(count:183)
Chromatin interactive
region (count:9)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:66 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr5:116398268-116398287	GM10266	blood:	n/a	n/a
2	E2F4	chr5:116379588-116379788	MCF10A-Er-Src	breast:	n/a	n/a
3	EP300	chr5:116400164-116402158	SK-N-SH	brain:	n/a	chr5:116401243-116401257 chr5:116401470-116401484 chr5:116402023-116402037
4	EP300	chr5:116401554-116401822	SK-N-SH_RA	brain:	n/a	n/a
5	FOS	chr5:116380768-116380964	MCF10A-Er-Src	breast:	n/a	chr5:116380883-116380892 chr5:116380885-116380892 chr5:116380882-116380894 chr5:116380884-116380893 chr5:116380884-116380892
6	FOS	chr5:116368715-116368802	MCF10A-Er-Src	breast:	n/a	n/a
7	FOS	chr5:116394463-116394663	MCF10A-Er-Src	breast:	n/a	n/a
8	FOXA2	chr5:116382919-116383157	A549	lung:	n/a	n/a
9	FOXA2	chr5:116382896-116383280	A549	lung:	n/a	n/a
10	GATA2	chr5:116401447-116401891	SH-SY5Y	brain:	n/a	n/a
11	GATA2	chr5:116400493-116400894	SH-SY5Y	brain:	n/a	n/a
12	GATA3	chr5:116401542-116401893	SH-SY5Y	brain:	n/a	n/a
13	GATA3	chr5:116395658-116395767	SH-SY5Y	brain:	n/a	n/a
14	GATA3	chr5:116400513-116400782	SH-SY5Y	brain:	n/a	n/a
15	GATA3	chr5:116401531-116401916	SK-N-SH	brain:	n/a	n/a
16	GTF2F1	chr5:116378046-116378179	H1-hESC	embryonic stem cell:	n/a	n/a
17	JUN	chr5:116390602-116390743	H1-hESC	embryonic stem cell:	n/a	n/a
18	JUN	chr5:116366214-116366310	H1-hESC	embryonic stem cell:	n/a	n/a
19	JUN	chr5:116380496-116380617	K562	blood:	n/a	n/a
20	JUND	chr5:116366691-116366971	HepG2	liver:	n/a	chr5:116366838-116366847
21	JUND	chr5:116380714-116381040	HepG2	liver:	n/a	chr5:116380883-116380892 chr5:116380885-116380892 chr5:116380882-116380893 chr5:116380882-116380894 chr5:116380884-116380893 chr5:116380884-116380892
22	MAFF	chr5:116379076-116379325	HepG2	liver:	n/a	chr5:116379203-116379221
23	MAFF	chr5:116374729-116374863	HepG2	liver:	n/a	chr5:116374812-116374830
24	MAFK	chr5:116374711-116374954	HepG2	liver:	n/a	chr5:116374813-116374827 chr5:116374814-116374829 chr5:116374775-116374785
25	MAFK	chr5:116406006-116406240	HepG2	liver:	n/a	n/a
26	MAFK	chr5:116374693-116374929	HepG2	liver:	n/a	chr5:116374813-116374827 chr5:116374814-116374829 chr5:116374775-116374785
27	MAFK	chr5:116379065-116379361	HepG2	liver:	n/a	chr5:116379093-116379108 chr5:116379208-116379225
28	MAFK	chr5:116379073-116379322	HepG2	liver:	n/a	chr5:116379093-116379108 chr5:116379208-116379225
29	MAFK	chr5:116374804-116374904	IMR90	lung:	n/a	chr5:116374813-116374827 chr5:116374814-116374829
30	MAFK	chr5:116379128-116379294	IMR90	lung:	n/a	chr5:116379208-116379225
31	MXI1	chr5:116371123-116371171	GM12878	blood:	n/a	n/a
32	MXI1	chr5:116401231-116402098	SK-N-SH	brain:	n/a	n/a
33	NANOG	chr5:116377965-116378309	H1-hESC	embryonic stem cell:	n/a	n/a
34	NFYA	chr5:116404735-116404920	GM12878	blood:	n/a	n/a
35	NFYB	chr5:116366040-116366240	GM12878	blood:	n/a	n/a
36	NRF1	chr5:116391237-116391312	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr5:116390806-116391154	SK-N-MC	brain:	n/a	n/a
38	POLR2A	chr5:116404592-116404726	GM12878	blood:	n/a	n/a
39	POLR2A	chr5:116405328-116405455	MCF10A-Er-Src	breast:	n/a	n/a
40	POLR2A	chr5:116397979-116398077	MCF10A-Er-Src	breast:	n/a	n/a
41	POLR2A	chr5:116386826-116387006	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr5:116385571-116385695	H1-hESC	embryonic stem cell:	n/a	n/a
43	POLR2A	chr5:116404733-116404734	GM12878	blood:	n/a	n/a
44	POLR2A	chr5:116375278-116375313	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr5:116390513-116390526	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr5:116376515-116376614	Hela-S3	cervix:	n/a	n/a
47	POLR2A	chr5:116397141-116397635	SK-N-MC	brain:	n/a	n/a
48	POLR2A	chr5:116392585-116392677	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr5:116393254-116393444	MCF10A-Er-Src	breast:	n/a	n/a
50	POLR2A	chr5:116376628-116376664	Hela-S3	cervix:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:116378307-116378357	BJ	skin:	n/a
2	chr5:116385443-116385493	AG10803	skin:	n/a
3	chr5:116385443-116385493	ProgFib	skin:	n/a
4	chr5:116378307-116378357	HPAEpiC	pulmonary alveolar:	n/a
5	chr5:116385443-116385493	AG04449	skin:	fetal
6	chr5:116385443-116385493	U87	brain:	n/a
7	chr5:116385300-116385350	HRE	kidney:	n/a
8	chr5:116378307-116378357	HEEpiC	esophagus:	n/a
9	chr5:116385443-116385493	IMR90	lung:	fetal
10	chr5:116378307-116378357	HUVEC	blood vessel:	n/a
11	chr5:116385300-116385350	ProgFib	skin:	n/a
12	chr5:116378307-116378357	HCF	heart:	n/a
13	chr5:116385443-116385493	HepG2	liver:	n/a
14	chr5:116378307-116378357	HNPCEpiC	eye:	n/a
15	chr5:116378307-116378357	GM19239	blood:	n/a
16	chr5:116378307-116378357	HEK293	kidney:	embryo
17	chr5:116378307-116378357	ovcar-3	ovarian:	n/a
18	chr5:116378307-116378357	MCF10A-Er-Src	breast:	n/a
19	chr5:116385300-116385350	HNPCEpiC	eye:	n/a
20	chr5:116385443-116385493	GM19239	blood:	n/a
21	chr5:116385443-116385493	HRPEpiC	eye:	n/a
22	chr5:116385443-116385493	GM12891	blood:	n/a
23	chr5:116385300-116385350	T-47D	breast:	n/a
24	chr5:116385300-116385350	GM06990	blood:	n/a
25	chr5:116378307-116378357	HAEpiC	amniotic membrane:	n/a
26	chr5:116385443-116385493	RPTEC	kidney:	n/a
27	chr5:116378307-116378357	CMK	blood:	n/a
28	chr5:116385443-116385493	HRE	kidney:	n/a
29	chr5:116378307-116378357	GM12878	blood:	n/a
30	chr5:116378307-116378357	HCT-116	colon:	n/a
31	chr5:116385300-116385350	AG09309	skin:	n/a
32	chr5:116378307-116378357	PrEC	prostate:	n/a
33	chr5:116385443-116385493	BJ	skin:	n/a
34	chr5:116378307-116378357	AG09309	skin:	n/a
35	chr5:116385443-116385493	HNPCEpiC	eye:	n/a
36	chr5:116385300-116385350	GM12891	blood:	n/a
37	chr5:116385300-116385350	AG04449	skin:	fetal
38	chr5:116385300-116385350	GM12878	blood:	n/a
39	chr5:116378307-116378357	AG10803	skin:	n/a
40	chr5:116378307-116378357	RPTEC	kidney:	n/a
41	chr5:116385300-116385350	HL-60	blood:	n/a
42	chr5:116385300-116385350	HAEpiC	amniotic membrane:	n/a
43	chr5:116378307-116378357	HCM	heart:	n/a
44	chr5:116385443-116385493	CMK	blood:	n/a
45	chr5:116385443-116385493	MCF-7	breast:	n/a
46	chr5:116378307-116378357	HRE	kidney:	n/a
47	chr5:116385443-116385493	AoSMC	blood vessel:	n/a
48	chr5:116385443-116385493	HIPEpiC	eye:	n/a
49	chr5:116385300-116385350	HCF	heart:	n/a
50	chr5:116385300-116385350	BE2_C	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:116360894..116363806-chr5:116375344..116377265,2	MCF-7	breast:
2	chr5:116381480..116384331-chr5:116390056..116392321,2	K562	blood:
3	chr5:116370263..116371870-chr5:116372681..116375033,2	K562	blood:
4	chr5:116370263..116371870-chr5:116372681..116375033,2	K562	blood:
5	chr5:116403228..116405101-chr5:116405267..116406890,2	K562	blood:
6	chr5:116388114..116390786-chr5:116391482..116393970,2	K562	blood:
7	chr5:116388114..116390786-chr5:116391482..116393970,2	K562	blood:
8	chr5:116403228..116405101-chr5:116405267..116406890,2	K562	blood:
9	chr5:116381480..116384331-chr5:116390056..116392321,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SEMA6A-8	chr5:116387796-116387856	NONHSAT103384
2	lnc-COMMD10-4	chr5:116366896-116367126	XLOC_004521
3	lnc-SEMA6A-8	chr5:116382515-116382695	NONHSAT103384
4	lnc-COMMD10-4	chr5:116374077-116374265	XLOC_004521

No data

Variant related genes	Relation type
ENSG00000250949	TF binding region
ENSG00000250949	CpG island
RBFOX2	miRNA target sites

Extended variants
information (count: 2080 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:2080 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540928860	chr5:116364886-116364887	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs554475477	chr5:116364893-116364894	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs574099984	chr5:116364919-116364920	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs201111109	chr5:116364926-116364927	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs191002033	chr5:116364948-116364949	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs562871710	chr5:116364971-116364972	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs528352598	chr5:116365001-116365002	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs78932040	chr5:116365112-116365113	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs531833218	chr5:116365163-116365164	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs373369266	chr5:116365192-116365193	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs539067334	chr5:116365203-116365204	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs564316080	chr5:116365238-116365239	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs532938544	chr5:116365255-116365256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs546907873	chr5:116365256-116365257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs567961393	chr5:116365258-116365259	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs528886320	chr5:116365272-116365273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs550221381	chr5:116365287-116365288	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs143935048	chr5:116365317-116365318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs528884016	chr5:116365324-116365325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs548566016	chr5:116365362-116365363	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs568900202	chr5:116365408-116365409	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs79128958	chr5:116365484-116365485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs557519293	chr5:116365551-116365552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs147261007	chr5:116365562-116365563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs377453240	chr5:116365569-116365570	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs140715338	chr5:116365619-116365620	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs4318816	chr5:116365679-116365680	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs558707294	chr5:116365709-116365710	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543094605	chr5:116365719-116365720	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs73256916	chr5:116365771-116365772	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs150820825	chr5:116365780-116365781	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs555222602	chr5:116365790-116365791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs571061597	chr5:116365800-116365801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs80141215	chr5:116365801-116365802	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs139425867	chr5:116365830-116365831	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs575011510	chr5:116365886-116365887	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs540015245	chr5:116365907-116365908	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs560062426	chr5:116365909-116365910	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs567109744	chr5:116365913-116365914	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs114212779	chr5:116365944-116365945	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs562505526	chr5:116365972-116365973	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs531178172	chr5:116366029-116366030	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs141982191	chr5:116366031-116366032	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs138720389	chr5:116366038-116366039	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs397688707	chr5:116366039-116366040	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs397751947	chr5:116366040-116366041	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs115458518	chr5:116366047-116366048	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs553672195	chr5:116366052-116366053	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs185721579	chr5:116366074-116366075	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs534425209	chr5:116366079-116366080	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
Colorectal cancer	16272173	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Ovarian cancer	21720365	CNVD
Salivary gland tumor	18059337	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Prostate cancer	16461572	CNVD
Myelofibrosis	22110671	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Glaucoma	21310917	CNVD
Glioblastoma multiforme	22286061	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:160 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:116356600-116366800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr5:116362600-116366600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr5:116365200-116365800	Enhancers	Fetal Lung	lung
4	chr5:116366800-116367200	ZNF genes & repeats	ES-I3 Cell Line	embryonic stem cell
5	chr5:116367200-116376400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr5:116369200-116369400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
7	chr5:116370600-116376600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr5:116372000-116372800	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
9	chr5:116372800-116388200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr5:116373600-116374400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr5:116374000-116374200	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr5:116374200-116377000	Weak transcription	HUES64 Cell Line	embryonic stem cell
13	chr5:116376200-116378200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr5:116376400-116377800	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr5:116376600-116377000	Enhancers	H9 Cell Line	embryonic stem cell
16	chr5:116376600-116377200	Enhancers	H1 Cell Line	embryonic stem cell
17	chr5:116376600-116377400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr5:116376600-116379400	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr5:116376800-116377200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr5:116376800-116377800	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr5:116376800-116379400	Enhancers	iPS-15b Cell Line	embryonic stem cell
22	chr5:116377000-116377800	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr5:116377000-116377800	Enhancers	iPS-18 Cell Line	embryonic stem cell
24	chr5:116377000-116379000	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr5:116377200-116379200	Weak transcription	H1 Cell Line	embryonic stem cell
26	chr5:116377400-116377800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr5:116377600-116377800	Enhancers	iPS-20b Cell Line	embryonic stem cell
28	chr5:116377800-116378000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr5:116377800-116378000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
30	chr5:116377800-116378000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
31	chr5:116377800-116378000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
32	chr5:116377800-116378200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
33	chr5:116377800-116378400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
34	chr5:116378000-116378200	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr5:116378000-116378400	Active TSS	HUES48 Cell Line	embryonic stem cell
36	chr5:116378000-116378400	Active TSS	iPS-20b Cell Line	embryonic stem cell
37	chr5:116378000-116378600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr5:116378000-116379000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr5:116378200-116378400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
40	chr5:116378200-116379400	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr5:116378400-116378600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
42	chr5:116378400-116379400	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr5:116378400-116379400	Enhancers	HUES64 Cell Line	embryonic stem cell
44	chr5:116378400-116379600	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr5:116378600-116379600	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr5:116379000-116379400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr5:116379000-116379400	Enhancers	H9 Cell Line	embryonic stem cell
48	chr5:116379200-116379400	Enhancers	H1 Cell Line	embryonic stem cell
49	chr5:116379400-116380400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr5:116379400-116381200	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links